EUVIMEDEUVIMED entdecken
Vergleichsstudie

Non‐Steroidal Anti‐Inflammatory Drug Versus Acetaminophen Initiation at Influenza Diagnosis and 14‐Day Neuropsychiatric Diagnoses in Adults: A Target Trial Emulation Using Japanese Claims Data

Satoshi Kutsuna iD, Shungo Yamamoto iD, Yoshiki Kusama

Pharmacoepidemiology and Drug Safety · 2026-11 · 35 (11)

DOI: 10.1002/pds.70513 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 29.10.2026. Verfasst von Satoshi Kutsuna und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control and Prevention, The University of Osaka Hospital, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Acetaminophen, Anti-Inflammatory Agents, Non-Steroidal, Influenza, Human. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

After case series in which diclofenac and mefenamic acid were associated with worse outcomes in children with established influenza‐associated encephalopathy, Japan recommended acetaminophen for influenza fever in 2001. We estimated the 14‐day risk of newly recorded neuropsychiatric diagnoses after initiating a non‐steroidal anti‐inflammatory drug (NSAID) versus acetaminophen at influenza diagnosis in adults, a related but distinct question.

Methods

Using the JMDC Claims Database (2018–2025), we emulated an active‐comparator, new‐prescription‐user target trial in adults aged 18–64 years. Time zero was an influenza diagnosis with a same‐day, same‐facility prescription of an oral or rectal NSAID or single‐agent acetaminophen; the initial prescription defined the group. The outcome was a broad neuropsychiatric composite newly recorded on Days 1–14 after a 365‐day component‐specific diagnosis‐free period. We estimated the average treatment effect in the propensity‐score overlap population using overlap weighting.

Results

Among 1 125 391 eligible adults, 140 877 (12.5%) initiated an NSAID (85.9% loxoprofen) and 984 514 initiated acetaminophen. The composite occurred in 112 and 699 episodes; overlap‐weighted 14‐day risks were 79.6 and 71.2 per 100 000 (risk ratio: 1.12, 95% CI: 0.92–1.36; risk difference 8.4 per 100 000, 95% CI: −7.2 to 24.0). Estimates were similar across outcome definitions and sensitivity analyses. Diclofenac and mefenamic acid were too rarely prescribed to evaluate.

Conclusions

In adults, NSAID initiation, predominantly loxoprofen, showed no clear difference in short‐term neuropsychiatric diagnoses compared with acetaminophen, although a relative increase of up to 36% and residual confounding by presenting symptoms were not excluded. The findings do not address diclofenac, mefenamic acid, children or established influenza‐associated encephalopathy. Trials Registration UMIN000062444.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenAnti-Inflammatory Agents, Non-SteroidalInfluenza, HumanHumansAdultJapanFemaleMaleMiddle AgedAdolescentYoung AdultDatabases, FactualDiclofenacMefenamic AcidAnalgesics, Non-NarcoticEast Asian PeoplePhenylpropionates

Stichwörter der Autor:innen

acetaminophenclaims dataencephalopathyinfluenzanon‐steroidal anti‐inflammatory drugspharmacoepidemiologytarget trial emulation

Substanzen

AcetaminophenAnti-Inflammatory Agents, Non-SteroidalDiclofenacMefenamic AcidAnalgesics, Non-NarcoticloxoprofenPhenylpropionates

Autor:innen und Institutionen

  • Department of Infection Control and Prevention, The University of Osaka Hospital, Suita, Osaka, Japan.
  • Center for Infectious Disease Education and Research, The University of Osaka, Suita, Osaka, Japan.
  • Department of Transformative Analysis for Human Specimen, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.
  • Department of Transformative Protection to Infectious Disease, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan.

ORCID-Profile: Satoshi Kutsuna, Shungo Yamamoto

Zitieren

APA

Kutsuna, S., Yamamoto, S., & Kusama, Y. (2026). Non‐Steroidal Anti‐Inflammatory Drug Versus Acetaminophen Initiation at Influenza Diagnosis and 14‐Day Neuropsychiatric Diagnoses in Adults: A Target Trial Emulation Using Japanese Claims Data. Pharmacoepidemiology and Drug Safety, 35(11). https://doi.org/10.1002/pds.70513

Vancouver

Kutsuna S, Yamamoto S, Kusama Y. Non‐Steroidal Anti‐Inflammatory Drug Versus Acetaminophen Initiation at Influenza Diagnosis and 14‐Day Neuropsychiatric Diagnoses in Adults: A Target Trial Emulation Using Japanese Claims Data. Pharmacoepidemiology and Drug Safety. 2026;35(11). doi:10.1002/pds.70513

BibTeX
@article{Kutsuna2026,
  author = {Kutsuna, Satoshi and Yamamoto, Shungo and Kusama, Yoshiki},
  title = {Non‐Steroidal Anti‐Inflammatory Drug Versus Acetaminophen Initiation at Influenza Diagnosis and 14‐Day Neuropsychiatric Diagnoses in Adults: A Target Trial Emulation Using Japanese Claims Data},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  volume = {35},
  number = {11},
  doi = {10.1002/pds.70513}
}
Kostenlos starten →